These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 33844936)

  • 1. Lessons from Cancer Metabolism for Pulmonary Arterial Hypertension and Fibrosis.
    Han S; Chandel NS
    Am J Respir Cell Mol Biol; 2021 Aug; 65(2):134-145. PubMed ID: 33844936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism.
    Judge A; Dodd MS
    Essays Biochem; 2020 Oct; 64(4):607-647. PubMed ID: 32830223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular Metabolism at a Glance.
    Mesquita I; Rodrigues F
    Exp Suppl; 2018; 109():3-27. PubMed ID: 30535597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SnapShot: Cancer metabolism.
    Brunner JS; Finley LWS
    Mol Cell; 2021 Sep; 81(18):3878-3878.e1. PubMed ID: 34547243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity in lung (18)FDG uptake in pulmonary arterial hypertension: potential of dynamic (18)FDG positron emission tomography with kinetic analysis as a bridging biomarker for pulmonary vascular remodeling targeted treatments.
    Zhao L; Ashek A; Wang L; Fang W; Dabral S; Dubois O; Cupitt J; Pullamsetti SS; Cotroneo E; Jones H; Tomasi G; Nguyen QD; Aboagye EO; El-Bahrawy MA; Barnes G; Howard LS; Gibbs JS; Gsell W; He JG; Wilkins MR
    Circulation; 2013 Sep; 128(11):1214-24. PubMed ID: 23900048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic perturbations in fibrosis disease.
    Ung CY; Onoufriadis A; Parsons M; McGrath JA; Shaw TJ
    Int J Biochem Cell Biol; 2021 Oct; 139():106073. PubMed ID: 34461262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic role of PET/MRI hybrid imaging in patients with pulmonary arterial hypertension.
    Kazimierczyk R; Szumowski P; Nekolla SG; Blaszczak P; Malek LA; Milosz-Wieczorek B; Misko J; Jurgilewicz D; Hladunski M; Knapp M; Sobkowicz B; Mysliwiec J; Grzywna R; Musial WJ; Kaminski KA
    Heart; 2021 Jan; 107(1):54-60. PubMed ID: 32522819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging Cancer Metabolism with Positron Emission Tomography (PET).
    Witney TH; Lewis DY
    Methods Mol Biol; 2019; 1928():29-44. PubMed ID: 30725448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism in Pulmonary Hypertension.
    Xu W; Janocha AJ; Erzurum SC
    Annu Rev Physiol; 2021 Feb; 83():551-576. PubMed ID: 33566674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The right ventricle in pulmonary arterial hypertension: disorders of metabolism, angiogenesis and adrenergic signaling in right ventricular failure.
    Ryan JJ; Archer SL
    Circ Res; 2014 Jun; 115(1):176-88. PubMed ID: 24951766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stalling the engine of resistance: targeting cancer metabolism to overcome therapeutic resistance.
    Butler EB; Zhao Y; Muñoz-Pinedo C; Lu J; Tan M
    Cancer Res; 2013 May; 73(9):2709-17. PubMed ID: 23610447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stress eating and tuning out: cancer cells re-wire metabolism to counter stress.
    Stine ZE; Dang CV
    Crit Rev Biochem Mol Biol; 2013; 48(6):609-19. PubMed ID: 24099138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic dysfunction in pulmonary hypertension: the expanding relevance of the Warburg effect.
    Cottrill KA; Chan SY
    Eur J Clin Invest; 2013 Aug; 43(8):855-65. PubMed ID: 23617881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic Pathways Fueling the Endothelial Cell Drive.
    Li X; Kumar A; Carmeliet P
    Annu Rev Physiol; 2019 Feb; 81():483-503. PubMed ID: 30742787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging Cancer Metabolism: Underlying Biology and Emerging Strategies.
    Pantel AR; Ackerman D; Lee SC; Mankoff DA; Gade TP
    J Nucl Med; 2018 Sep; 59(9):1340-1349. PubMed ID: 30042161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective deletion of connective tissue growth factor attenuates experimentally-induced pulmonary fibrosis and pulmonary arterial hypertension.
    Tam AYY; Horwell AL; Trinder SL; Khan K; Xu S; Ong V; Denton CP; Norman JT; Holmes AM; Bou-Gharios G; Abraham DJ
    Int J Biochem Cell Biol; 2021 May; 134():105961. PubMed ID: 33662577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic Reprogramming and Redox Signaling in Pulmonary Hypertension.
    Plecitá-Hlavatá L; D'alessandro A; El Kasmi K; Li M; Zhang H; Ježek P; Stenmark KR
    Adv Exp Med Biol; 2017; 967():241-260. PubMed ID: 29047090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shifts in myocardial fatty acid and glucose metabolism in pulmonary arterial hypertension: a potential mechanism for a maladaptive right ventricular response.
    Ohira H; deKemp R; Pena E; Davies RA; Stewart DJ; Chandy G; Contreras-Dominguez V; Dennie C; Mc Ardle B; Mc Klein R; Renaud JM; DaSilva JN; Pugliese C; Dunne R; Beanlands R; Mielniczuk LM
    Eur Heart J Cardiovasc Imaging; 2016 Dec; 17(12):1424-1431. PubMed ID: 26060207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung ¹⁸F-fluorodeoxyglucose positron emission tomography for diagnosis and monitoring of pulmonary arterial hypertension.
    Marsboom G; Wietholt C; Haney CR; Toth PT; Ryan JJ; Morrow E; Thenappan T; Bache-Wiig P; Piao L; Paul J; Chen CT; Archer SL
    Am J Respir Crit Care Med; 2012 Mar; 185(6):670-9. PubMed ID: 22246173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mammalian target of rapamycin complex 2 (mTORC2) coordinates pulmonary artery smooth muscle cell metabolism, proliferation, and survival in pulmonary arterial hypertension.
    Goncharov DA; Kudryashova TV; Ziai H; Ihida-Stansbury K; DeLisser H; Krymskaya VP; Tuder RM; Kawut SM; Goncharova EA
    Circulation; 2014 Feb; 129(8):864-74. PubMed ID: 24270265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.